Search research articles
Contact Us
Filters
Showing results (261-270 of 393) with videos related to
Page
of 40
Sort By:
Medical Oncology (Northwood, London, England)
|
December 28, 2019
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy
Florence Chamberlain, Elena Cojocaru, Mariana Scaranti, et al.
JCO Global Oncology
|
July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers
Alannah Smrke, Eugenie Younger, Roger Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Medical Oncology (Northwood, London, England)
|
April 15, 2010
Chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou, Khin Thway, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Clinical Sarcoma Research
|
January 9, 2020
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
Florence Chamberlain, Sheima Farag, Constance Williams-Sharkey, et al.
Journal of Adolescent and Young Adult Oncology
|
May 8, 2020
Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience
Eugenie Younger, Olga Husson, Bernice Asare, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
JCO Global Oncology
|
June 30, 2021
What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland
Holly M McCabe, Alannah Smrke, Fiona Cowie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors
Robin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Page
of 40
Search research articles
Search
Showing results (261-270 of 393) with videos related to
Sort By:
Page
of 40
Medical Oncology (Northwood, London, England)
|
December 28, 2019
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy
Florence Chamberlain, Elena Cojocaru, Mariana Scaranti, et al.
JCO Global Oncology
|
July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers
Alannah Smrke, Eugenie Younger, Roger Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Medical Oncology (Northwood, London, England)
|
April 15, 2010
Chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou, Khin Thway, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Clinical Sarcoma Research
|
January 9, 2020
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
Florence Chamberlain, Sheima Farag, Constance Williams-Sharkey, et al.
Journal of Adolescent and Young Adult Oncology
|
May 8, 2020
Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience
Eugenie Younger, Olga Husson, Bernice Asare, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
JCO Global Oncology
|
June 30, 2021
What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland
Holly M McCabe, Alannah Smrke, Fiona Cowie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors
Robin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Page
of 40